Brian Mueller insider trades

Open-market stock purchases and sales by Brian Mueller, EVP, Chief Financial Officer at Biomarin Pharmaceutical Inc, from SEC Form 4 filings since Apr 29, 2011.

Recent trades

DateStockTradeValue
Mar 17, 2026BMRN Biomarin Pharmaceutical IncSold (not open market)$119K
Mar 16, 2026BMRN Biomarin Pharmaceutical IncBought (not open market)—
Mar 16, 2026BMRN Biomarin Pharmaceutical IncBought (not open market)—
Mar 13, 2026BMRN Biomarin Pharmaceutical IncSold (not open market)$582K
Feb 25, 2026BMRN Biomarin Pharmaceutical IncBought (not open market)—
Feb 25, 2026BMRN Biomarin Pharmaceutical IncBought (not open market)—
Feb 25, 2026BMRN Biomarin Pharmaceutical IncBought (not open market)—

Companies traded

  • BMRN Biomarin Pharmaceutical Inc: 44 sales, last Mar 17, 2026
  • ANTH Anthera Pharmaceuticals Inc: other filings, last Jan 5, 2018

Get free alerts when Brian Mueller files a new trade →